Drugs / Neurocell-PD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00226460 | Aug 1997 → Jan 2001 | Parkinson disease | Genzyme, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neurocell-PD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00226460 ↗ |